Sheila D. Rege, MD

Sheila Rege, MD, was elected to the American Medical Association Board of Trustees in June 2025. She is a board-certified radiation oncologist and associate clinical professor at Washington State University’s Elson S. Floyd College of Medicine. Before specializing in radiation oncology, she earned board certification in nuclear medicine and molecular imaging at UCLA.

Dr. Rege has worked within academic, private hospitals and physician-owned organizations. Her past positions include director of research at LSU Shreveport, cancer program chair at Providence Kadlec Hospital in Richland, Wash., and medical director and board member of the Tri-Cities Cancer Center in Kennewick, Wash. She also served as medical director of a large, multi-specialty physician group, helping scale patient-centered, financially sustainable care models.

At the national level, she has served as chair and president of the board at the American College of Radiation Oncology (ACRO), chair of the AMA Council on Medical Service (2024), and advisor to the AMA CPT® and RUC committees—roles requiring expertise in reimbursement policy, regulatory frameworks and the adoption of emerging technologies. She has served on the Washington State Medical Association Board of Trustees and chaired the state’s Health Technology Clinical Committee, helping shape health coverage decisions for state-purchased plans based on clinical evidence and demonstrated effectiveness.

She currently serves on the board of directors for Mirion Technologies (NYSE: MIR), which operates in 12 countries worldwide and manufactures radiation safety devices for energy, aerospace, health care and laboratories. She previously served on the board of Physicians Insurance, a member-owned medical professional liability company, where she remains active on the Risk Committee, providing oversight on claims, enterprise risk and regulatory exposure.

Dr. Rege holds National Association of Corporate Directors (NACD) directorship certification and is certified in cyber-risk oversight through the NACD and Carnegie Mellon University. She also holds a Master of Science in finance from the University of the Cumberlands. She received her BA in biochemistry from UC Berkeley and her MD from UCLA, where she also completed residency and fellowship.

A committed mentor and advocate for emerging leaders, Dr. Rege has advised early stage ventures in AI and big data through a health care incubator program at the University of Washington Foster School of Business Creative Destruction Lab and has engaged in public education through her former radio show, “Cancer Chat with Dr. Rege.” Her contributions have been recognized nationally with the ACRO Gold Medal (2023), the Sucha Asbell Mentorship Award (2022), and the AMA WPS Inspiration Award (2021).

Dr. Rege is based in Washington’s Tri-Cities region and brings clinical, new technology and governance experience to the AMA board.

2025-2026

Board of Trustees speaker request form

To request a member of the AMA Board of Trustees to speak at an upcoming event, please read the terms and conditions, complete and submit the form.

For the media

• Download a high-resolution image
• For media inquiries, please contact [email protected]